The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2010Development of a Progressive Familial Pre-clinical Model of Parkinson's Disease
Objective/Rationale:
Although a number of genes have been identified that lead to Parkinson’s disease in humans, the scientific community has yet to be able to recapitulate this in pre-clinical... -
Clinical Intervention Awards, 2010Gastric-Retentive, Extended-Release Levodopa/Carbidopa Tablets Versus a Reference, Extended-Release Tablet in Parkinson's Disease
Objective/Rationale:
The objective of this project is to develop a gastric-retentive, extended-release tablet of levodopa/carbidopa (DM-1992) that will result in constant blood levels of levodopa... -
Clinical Intervention Awards, 2010Safety, Tolerability and Efficacy of ADX48621 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
Objective/Rationale:
The main objective of this study is to evaluate the effect of ADX48621 (dipraglurant) in reducing levodopa-induced dyskinesia in patients with Parkinson’s disease (PD). ADX48621... -
Clinical Intervention Awards, 2010Acupuncture as a Symptoms & Side Effects Treatment for Fatigue in Parkinson's Disease
Objective/Rationale:
Fatigue affects approximately half of all Parkinson’s disease patients and has a major impact on quality of life and disability. Unfortunately, Parkinson’s medications do not... -
Clinical Intervention Awards, 2010Maintenance of Continuous Plasma Levodopa Levels through Continuous Subcutaneous Carbidopa Administration
Objective/Rationale:
In Parkinson’s disease (PD) therapeutics, carbidopa is used together with levodopa to prevent its breakdown. This investigation will determine whether subcutaneous carbidopa... -
Rapid Response Innovation Awards, 2010Biomarkers and Immunotherapy for Parkinson's Disease
Objective/Rationale:
We theorize that the interplay between the immune system and the brain plays a substantive role in the progression of Parkinson’s disease. Moreover, we posit that the immune system...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.